Results 31 to 40 of about 5,890 (202)
Journal of Pakistan Association of Dermatologists, 2021 Objective To compare the efficacy of combined parenteral Meglumine Antimoniate and oral Allopurinol with Meglumine Antimoniate alone in the treatment of Cutaneous Leishmaniasis. Study Design Randomized controlled trial. Place and duration of study Department of Dermatology, Combined Military Hospital, Peshawar from May 2016- Oct 2016.
Jamshida Iqbal Khattak +2 more
openaire +1 more source
Comparison of Use of Intralesional Artemether with Intralesional Meglumine Antimoniate in Cutaneous Leishmaniasis [PDF]
, 2018 Objective: The objective of this study is to compare the efficacy and safety of Intralesional Meglumine Antimoniate and Intralesional Artemether in the Treatment of Cutaneous Leishmaniasis.Patients and Methods: Total 168 patients of cutaneous ...
Abdullah, Sumaira
core +2 more sources
Journal of Vector Borne Diseases, 2020 Background & objectives: Pentavalent antimonials are the standard treatment for cutaneous leishmaniasis (CL), however, treatment failures are frequent. Nimodipine, a calcium channel blocker is known to show promising antiprotozoal effects.
Reza Azadi +6 more
doaj +1 more source
Tissue distribution of residual antimony in rats treated with multiple doses of meglumine antimoniate [PDF]
Memórias do Instituto Oswaldo Cruz, 2014 Meglumine antimoniate (MA) and sodium stibogluconate are pentavalent antimony (SbV) drugs used since the mid-1940s. Notwithstanding the fact that they are first-choice drugs for the treatment of leishmaniases, there are gaps in our knowledge of their toxicological profile, mode of action and kinetics.
Coelho, Deise Riba +3 more
openaire +4 more sources
Pakistan Armed Forces Medical Journal, 2021 Objective: To compare the efficacy of oral chloroquine with systemic meglumine antimoniate in treatment of cutaneous leishmaniasis. Study Design: Open-label comparative prospective study.
Muhammad Farooq +3 more
doaj +1 more source
, 2019 The costs related to meglumine antimoniate intralesional infiltration and to endovenous meglumine antimoniate treatment.
Nayara C. Brito (8087945) +3 more
core +1 more source
, 2019 Cost-effectiveness analysis of meglumine antimoniate intralesional infiltration compared to endovenous meglumine antimoniate for cutaneous leishmaniasis treatment in Brazil.
Nayara C. Brito (8087945) +3 more
core +1 more source
, 2019 The costs related to adverse events to meglumine antimoniate intralesional infiltration and to endovenous meglumine antimoniate treatment.
Nayara C. Brito (8087945) +3 more
core +1 more source
Life and ScienceObjective: To evaluate the efficacy of the combination of oral allopurinol plus intralesional meglumine for the treatment of Cutaneous Leishmaniasis. Study Design: A prospective study.
Nida Qayyum +5 more
doaj +1 more source
The weight of the chick embryos following meglumine antimoniate treatment.
, 2018 The weight at days 6, 12 and 18 of the incubation period is presented with comparison between control (n = 30) and meglumine antimoniate-treated embryos at dosages of 75 (n = 30) or 150 (n = 30) mg per kg egg-weight.
Amin Derakhshanfar (5285756) +7 more
core +1 more source